Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 39.11M | $ 12.71M | 32.51% |
3/31/2025 | $ 42.18M | $ 5.14M | 12.19% |
12/31/2024 | $ 54.13M | $ 4.83M | 8.91% |
9/30/2024 | $ 32.93M | $ 6.82M | 20.72% |
6/30/2024 | $ 52.01M | $ 11.69M | 22.47% |
3/31/2024 | $ 66.31M | $ 7.1M | 10.7% |
12/31/2023 | $ 81.6M | $ 4.38M | 5.37% |
9/30/2023 | $ 97.15M | $ 2M | 2.06% |
6/30/2023 | $ 62.2M | $ 7.68M | 12.34% |
3/31/2023 | $ 68.64M | $ 7.84M | 11.43% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for VERRICA PHARMACEUTICALS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 79.94M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |